Acambis and Bavarian Settle Disputes

Acambis (Cambridge, UK, www.acambis.com) and Bavarian Nordic (Kvistg?rd, Denmark, www.bavarian-nordic.com) have reached a global settlement ending the legal disputes between the two companies on matters relating to smallpox vaccines based on the modified vaccinia ankara (MVA) virus.

Acambis (Cambridge, UK, www.acambis.com) and Bavarian Nordic (Kvistgård, Denmark, www.bavarian-nordic.com) have reached a global settlement ending the legal disputes between the two companies on matters relating to smallpox vaccines based on the modified vaccinia ankara (MVA) virus. Under the agreement, Bavarian Nordic will grant a license to some of its MVA patents in return for making an undisclosed upfront payment from Acambis.